Vincristine and prednisone vs vincristine, l-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in children
Authors:
- 1 January 1979
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 6 (4) , 317-323
Abstract
Second remission induction rates for vincristine and prednisone alone (VP) and vincristine, L‐asparaginase, and prednisone (VLP) are compared for children with acute lymphocytic leukemia. No evidence of a significant difference between the second induction complete remission rate for VP (78.6%) and VLP (73.7%) was found. Duration of first remission and prognostic group at initial diagnosis (defined on the basis of age and white blood count at initial diagnosis) are shown to be significant prognostic factors for second remission induction; and three second remission induction risk groups are defined on the basis of these two factors. Periodic reinforcement with prednisone in first remission does not appear to lower second induction complete response (CR) rates for VP. There was no evidence of a significant difference in the frequency of occurrence of severe toxicity between the VP and VLP regimens.Keywords
This publication has 4 references indexed in Scilit:
- A computer program for linear logistic regression analysisComputer Programs in Biomedicine, 1974
- Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970Cancer, 1973
- Toxicity of L-asparaginase in children with advanced leukemiaCancer, 1972
- L-asparaginase therapy in children with advanced leukemiaThe Southwest cancer chemotherapy study groupCancer, 1971